PDF herunterladen
Semin intervent Radiol 2021; 38(02): 215-225
DOI: 10.1055/s-0041-1729743
Review Article

Management of Venous Malformations

Michael Acord
1   Department of Radiology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
,
Abhay Srinivasan
1   Department of Radiology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Venous malformations (VMs) are slow-flow, congenital vascular anomalies that are a result of vascular dysgenesis. Clinical presentation and morbidity depend on size, location, and association with other syndromes. VMs are the most common symptomatic vascular anomaly referred for intervention, usually due to thrombosis, swelling, mass effect, functional compromise, or cosmetic concerns. Treatment for larger lesions can be challenging and a multidisciplinary approach involving medical, interventional, and surgical input is critical for comprehensive care. This article will assist the interventional radiologist in patient assessment and will discuss current techniques for treatment, means to minimize adverse events, and expected outcomes.

Keywords

venous malformation - sclerotherapy - pediatric - interventional radiology - embolization


Publikationsverlauf

Artikel online veröffentlicht:
03. Juni 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Wassef M, Blei F, Adams D. et al; ISSVA Board and Scientific Committee. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136 (01) e203-e214
    CrossrefPubMedGoogle Scholar
  • 2 Cooke-Barber J, Kreimer S, Patel M, Dasgupta R, Jeng M. Venous malformations. Semin Pediatr Surg 2020; 29 (05) 150976
    CrossrefPubMedGoogle Scholar
  • 3 Zúñiga-Castillo M, Teng CL, Teng JMC. Genetics of vascular malformation and therapeutic implications. Curr Opin Pediatr 2019; 31 (04) 498-508
    CrossrefPubMedGoogle Scholar
  • 4 Hage AN, Chick JFB, Srinivasa RN. et al. Treatment of venous malformations: the data, where we are, and how it is done. Tech Vasc Interv Radiol 2018; 21 (02) 45-54
    CrossrefPubMedGoogle Scholar
  • 5 Fereydooni A, Dardik A, Nassiri N. Molecular changes associated with vascular malformations. J Vasc Surg 2019; 70 (01) 314-326.e1
    CrossrefPubMedGoogle Scholar
  • 6 Marie A, Els C, Francine L. Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology. Cardiovasc Intervent Radiol 2011; 34 (04) 691-704
    CrossrefPubMedGoogle Scholar
  • 7 Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg 2012; 68 (02) 198-201
    CrossrefPubMedGoogle Scholar
  • 8 Vogel SA, Hess CP, Dowd CF. et al. Early versus later presentations of venous malformations: where and why?. Pediatr Dermatol 2013; 30 (05) 534-540
    CrossrefPubMedGoogle Scholar
  • 9 Dalmonte P, Granata C, Fulcheri E, Vercellino N, Gregorio S, Magnano G. Intra-articular venous malformations of the knee. J Pediatr Orthop 2012; 32 (04) 394-398
    CrossrefPubMedGoogle Scholar
  • 10 Reis III J, Alomari AI, Trenor III CC. et al. Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trénaunay syndrome. J Vasc Surg Venous Lymphat Disord 2018; 6 (04) 511-516
    CrossrefPubMedGoogle Scholar
  • 11 Esposito F, Ferrara D, Di Serafino M. et al. Classification and ultrasound findings of vascular anomalies in pediatric age: the essential. J Ultrasound 2019; 22 (01) 13-25
    CrossrefPubMedGoogle Scholar
  • 12 Behravesh S, Yakes W, Gupta N. et al. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther 2016; 6 (06) 557-569
    CrossrefPubMedGoogle Scholar
  • 13 Alomari AI. Diversion venography--a modified technique in Klippel-Trenaunay syndrome: initial experience. J Vasc Interv Radiol 2010; 21 (05) 685-689
    CrossrefPubMedGoogle Scholar
  • 14 Olivieri B, White CL, Restrepo R, McKeon B, Karakas SP, Lee EY. Low-flow vascular malformation pitfalls: from clinical examination to practical imaging evaluation - Part 2, venous malformation mimickers. AJR Am J Roentgenol 2016; 206 (05) 952-962
    CrossrefPubMedGoogle Scholar
  • 15 Dompmartin A, Acher A, Thibon P. et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 2008; 144 (07) 873-877
    CrossrefPubMedGoogle Scholar
  • 16 Aronniemi J, Castrén E, Lappalainen K. et al. Sclerotherapy complications of peripheral venous malformations. Phlebology 2016; 31 (10) 712-722
    CrossrefPubMedGoogle Scholar
  • 17 Hung JWS, Leung MWY, Liu CSW. et al. Venous malformation and localized intravascular coagulopathy in children. Eur J Pediatr Surg 2017; 27 (02) 181-184
    PubMedGoogle Scholar
  • 18 Koo KSH, Dowd CF, Mathes EF. et al. MRI phenotypes of localized intravascular coagulopathy in venous malformations. Pediatr Radiol 2015; 45 (11) 1690-1695
    CrossrefPubMedGoogle Scholar
  • 19 Mactier C, Mathias M, Drebes A. Novel approach to management of localised intravascular coagulopathy in extensive low flow venous malformations using rivaroxaban. Blood 2016; 128 (22) 3785
    CrossrefPubMedGoogle Scholar
  • 20 Correll D. The measurement of pain: objectifying the subjective. In: Waldman S, Bloch J. eds. Pain Management. W.B. Saunders; 2007: 197-211
    CrossrefGoogle Scholar
  • 21 Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37 (02) 126-139
    CrossrefPubMedGoogle Scholar
  • 22 Gurgacz S, Zamora L, Scott NA. Percutaneous sclerotherapy for vascular malformations: a systematic review. Ann Vasc Surg 2014; 28 (05) 1335-1349
    CrossrefPubMedGoogle Scholar
  • 23 Chehab MA, Thakor AS, Tulin-Silver S. et al. Adult and pediatric antibiotic prophylaxis during vascular and IR procedures: a Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology. J Vasc Interv Radiol 2018; 29 (11) 1483-1501.e2
    CrossrefPubMedGoogle Scholar
  • 24 Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol 2003; 180 (05) 1399-1401
    CrossrefPubMedGoogle Scholar
  • 25 Legiehn GM. Sclerotherapy with adjunctive stasis of efflux (STASE) in venous malformations: techniques and strategies. Tech Vasc Interv Radiol 2019; 22 (04) 100630
    CrossrefPubMedGoogle Scholar
  • 26 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27 (01) 58-60
    PubMedGoogle Scholar
  • 27 Hashimoto K, Uchida B, Horikawa M, Mimura H, Farsad K. Effects of different mixing agents on the stability of sodium tetradecyl sulfate (STS) foam: an experimental study. Cardiovasc Intervent Radiol 2018; 41 (12) 1952-1957
    CrossrefPubMedGoogle Scholar
  • 28 Peterson JD, Goldman MP. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. Phlebology 2012; 27 (02) 73-76
    CrossrefPubMedGoogle Scholar
  • 29 Cavezzi A, Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 2009; 24 (06) 247-251
    CrossrefPubMedGoogle Scholar
  • 30 van der Vleuten CJM, Kater A, Wijnen MHWA, Schultze Kool LJ, Rovers MM. Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol 2014; 37 (04) 977-989
    PubMedGoogle Scholar
  • 31 Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 2004; 33 (05) 463-466
    CrossrefPubMedGoogle Scholar
  • 32 Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19 (12) 766-773
    CrossrefPubMedGoogle Scholar
  • 33 Spence J, Krings T, terBrugge KG, da Costa LB, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol 2010; 31 (05) 955-960
    CrossrefPubMedGoogle Scholar
  • 34 Horbach SER, Rigter IM, Smitt JHS, Reekers JA, Spuls PI, van der Horst CMAM. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg 2016; 137 (01) 244-256
    CrossrefPubMedGoogle Scholar
  • 35 Zhang W, Chen G, Ren JG, Zhao YF. Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br J Pharmacol 2013; 170 (06) 1210-1220
    CrossrefPubMedGoogle Scholar
  • 36 Ul Haq F, Mitchell SE, Tekes A, Weiss CR. Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol 2015; 26 (10) 1484-1493
    CrossrefPubMedGoogle Scholar
  • 37 Feldman D. Bleomycin-induced lung injury. 2020th ed.. In: Kantoff PW, Freedman AS, Helen H, MF SD. eds. UpToDate; 2019. . Accessed December 12, 2020 at: https://www.uptodate.com/contents/bleomycin-induced-lung-injury/print
    Google Scholar
  • 38 Teusch VI, Wohlgemuth WA, Hammer S. et al. Ethanol-gel sclerotherapy of venous malformations: effectiveness and safety. AJR Am J Roentgenol 2017; 209 (06) 1390-1395
    CrossrefPubMedGoogle Scholar
  • 39 Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 2001; 12 (05) 595-600
    CrossrefPubMedGoogle Scholar
  • 40 Yakes WF. Use of multiple sclerosant agents in vascular malformation management: a world in endovascular confusion and chaos. J Vasc Interv Radiol 2015; 26 (10) 1494-1496
    CrossrefPubMedGoogle Scholar
  • 41 Shin BS, Do YS, Cho HS. et al. Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol 2010; 21 (01) 81-89
    CrossrefPubMedGoogle Scholar
  • 42 Fereydooni A, Nassiri N. Evaluation and management of the lateral marginal vein in Klippel-Trénaunay and other PIK3CA-related overgrowth syndromes. J Vasc Surg Venous Lymphat Disord 2020; 8 (03) 482-493
    CrossrefPubMedGoogle Scholar
  • 43 Patel PA, Barnacle AM, Stuart S, Amaral JG, John PR. Endovenous laser ablation therapy in children: applications and outcomes. Pediatr Radiol 2017; 47 (10) 1353-1363
    CrossrefPubMedGoogle Scholar
  • 44 King K, Landrigan-Ossar M, Clemens R, Chaudry G, Alomari AI. The use of endovenous laser treatment in toddlers. J Vasc Interv Radiol 2013; 24 (06) 855-858
    CrossrefPubMedGoogle Scholar
  • 45 Huegel U, Baumgartner I. Implementation of new endovenous treatments in therapy for lateral embryonic veins. J Vasc Surg Cases Innov Tech 2019; 5 (03) 243-247
    CrossrefPubMedGoogle Scholar
  • 46 Lambert G, Teplisky D, Cabezas M. et al. Mechanochemical endovenous ablation of varicose veins in pediatric patients with Klippel-Trénaunay syndrome: feasibility, safety, and initial results. J Vasc Interv Radiol 2021; 32 (01) 80-86
    CrossrefPubMedGoogle Scholar
  • 47 Carabin J, Bouhamama A, Vaz G. et al. Percutaneous cryoablation of symptomatic intramuscular venous malformation. J Vasc Interv Radiol 2020; 31 (04) 558-563.e3
    CrossrefPubMedGoogle Scholar
  • 48 Shaikh R. Percutaneous image-guided cryoablation in vascular anomalies. Semin Intervent Radiol 2017; 34 (03) 280-287
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 49 Ramaswamy RS, Tiwari T, Darcy MD. et al. Cryoablation of low-flow vascular malformations. Diagn Interv Radiol 2019; 25 (03) 225-230
    CrossrefPubMedGoogle Scholar
  • 50 Gregory S, Burrows PE, Ellinas H, Stadler M, Chun RH. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: a safe and effective treatment option. Int J Pediatr Otorhinolaryngol 2018; 108 (108) 30-34
    CrossrefPubMedGoogle Scholar
  • 51 Rabe E, Partsch H, Hafner J. et al. Indications for medical compression stockings in venous and lymphatic disorders: an evidence-based consensus statement. Phlebology 2018; 33 (03) 163-184
    CrossrefPubMedGoogle Scholar
  • 52 Abess A, Keel DM, Graham BS. Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris. Arch Dermatol 2003; 139 (03) 337-339
    CrossrefPubMedGoogle Scholar
  • 53 Milbar HC, Jeon H, Ward MA, Mitchell SE, Weiss CR, Cohen BA. Hyperpigmentation after foamed bleomycin sclerotherapy for vascular malformations. J Vasc Interv Radiol 2019; 30 (09) 1438-1442
    CrossrefPubMedGoogle Scholar
  • 54 Méndez-Echevarría A, Fernandez-Prieto A, de la Serna O. et al. Acute lung toxicity after intralesional bleomycin sclerotherapy. Pediatrics 2018; 141 (01) e20161787
    CrossrefPubMedGoogle Scholar
  • 55 Atwa K, Abuhasna S, Shihab Z, Hashaykeh N, Hasan R. Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation. Pediatr Pulmonol 2010; 45 (02) 192-196
    CrossrefPubMedGoogle Scholar
  • 56 Stuart S, Barnacle AM, Smith G, Pitt M, Roebuck DJ. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children. Radiology 2015; 274 (03) 897-905
    CrossrefPubMedGoogle Scholar
  • 57 Hu X, Chen D, Jiang C. et al. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation. Head Neck 2011; 33 (11) 1616-1621
    CrossrefPubMedGoogle Scholar
  • 58 Sinha KR, Duckwiler G, Rootman DB. Urticarial reaction following endovascular embolization of an orbital arteriovenous malformation (AVM) with n-butyl cyanoacrylate (nBCA) glue. Interv Neuroradiol 2017; 23 (06) 666-668
    CrossrefPubMedGoogle Scholar
  • 59 Greene AK, Alomari AI. Management of venous malformations. Clin Plast Surg 2011; 38 (01) 83-93
    CrossrefPubMedGoogle Scholar
  • 60 Barranco-Pons R, Burrows PE, Ossar-Landrigan M. et al. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. Am J Roentgenol 2012; 199 (03) 691-694
    CrossrefPubMedGoogle Scholar